COMMUNIQUÉS West-GlobeNewswire

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
17/07/2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for [...]
Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
17/07/2025
HUNTSVILLE, Ontario, July 17, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, [...]
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
17/07/2025
More than 50% of patients saw treatment changes following Heartflow Plaque Analysis – driving promising LDL cholesterol improvements and individualized care MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. , [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a biotech company dedicated to developing [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , société de biotechnologie qui [...]
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
17/07/2025
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and [...]
EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation
17/07/2025
Second-Quarter and First-Half 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation
17/07/2025
Second-Quarter and First-Half 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
17/07/2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- [...]
AI-Supported, Single-Center Cancer Model from Liv Hospital
17/07/2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced [...]
Professional Credit Renews HFMA Peer Review Designation
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA [...]
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
17/07/2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain [...]
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
17/07/2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY [...]
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
17/07/2025
WARREN, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. [...]
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
17/07/2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, [...]
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
17/07/2025
July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health [...]
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
17/07/2025
Family to Embark on an Unforgettable Trip, Courtesy of Stan and Naomi Loomis ORLANDO, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- Make-A-Wish® Central and Northern Florida , in collaboration with Stan and Naomi Loomis, co- [...]
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
17/07/2025
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the [...]
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
17/07/2025
LONDON and NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an [...]

Pages